EyePoint Pharmaceuticals
EYPT
EYPT
66 hedge funds and large institutions have $85.6M invested in EyePoint Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 19 increasing their positions, 19 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
11% less funds holding
Funds holding: 74 → 66 (-8)
17% less capital invested
Capital invested by funds: $103M → $85.6M (-$17M)
50% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 16
Holders
66
Holding in Top 10
2
Calls
$213K
Puts
$36K
Top Buyers
| 1 | +$1.06M | |
| 2 | +$662K | |
| 3 | +$193K | |
| 4 |
Morgan Stanley
New York
|
+$191K |
| 5 |
Renaissance Technologies
New York
|
+$139K |
Top Sellers
| 1 | -$1.71M | |
| 2 | -$457K | |
| 3 | -$324K | |
| 4 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$245K |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$200K |